Li et al., in their cross-sectional study, found for the first time that there was a positive and independent association between plasma PCSK9 levels and platelet counts in 330 patients with stable CAD, suggesting an association between high PCSK9 levels, platelets, atherosclerosis, and cardiovascular disease [44]. This evidence concerns the gene PCSK9 and atherosclerosis.